Hoed, C.M. den

pylori patient study ulcer peptic ulcer treatment prevalence cancer peptic lesion esomeprazole helicobacter omeprazole infection helicobacter pylori infection diagnosis gastriti effect premalignant subject gastroenterol therapy pylori infection endoscopic lymphoma group helicobacter pylori intragastric ph cohort barrett dysplasia population gmalt dlbcl intragastric children incidence difference chapter disease metaplasia premalignant lesions rebleeding endoscopy pantoprazole period incubation period result hgd /eac adenocarcinoma peptic ulcer disease inhibitor kuiper follow-up malt lymphoma antibody proton kuipers ej outcome aliment pharmacol administration netherland progression control table hgd /oac esophagus mortality surveillance randomized pylori prevalence development factor colonization eradication vries ac incubation trial range gastroenterology